非布司他可以根治痛风吗?
Can gout be cured? Gout is a relatively common disease, and the treatment cycle is relatively long. Gout is caused by excessive uric acid. Febuxostat tablets are suitable for the long-term treatment of hyperuricemia in patients with gout. Febuxostat is a 2-arylthiazole derivative that reduces serum uric acid concentration by inhibiting uric acid synthesis. Febuxostat can only relieve some symptoms and cannot cure gout.
Febuxostat is a xanthine oxidase (XO) inhibitor and is suitable for the long-term treatment of hyperuricemia with gout symptoms. Not recommended for asymptomatic hyperuricemia. Febuxostat has a specific uric acid-lowering effect without affecting other metabolic processes in the body.
The recommended starting dose of Febuxostat tablets is 40 mg once daily if after 2 weeks. The blood uric acid level is still not less than 6 mg/dl (about 360 μmol/L). It is recommended that the dose be increased to 80mg. Once a day. Food and antacid effects do not need to be considered when administering the drug.
As a new gout drug, febuxostat has quickly occupied the gout market due to its good therapeutic effect and low side effects since its launch, becoming the first choice for most patients. Febuxostat has a very rapid effect on lowering blood uric acid. Generally, if the oral medication is 40 mg per day, the blood uric acid level can reach the standard in 1-2 weeks. After Febuxostat was launched on the market, it has become the choice of more and more gout friends due to its "better acid-lowering effect and higher safety".
The editor reminds: Since gout is a disease that requires long-term treatment, long-term medication is naturally necessary. In addition, it is prohibited for those who are allergic to any component of the tablet. It is contraindicated in patients receiving azathioprine and mercaptopurine. It is not recommended for pregnant women to take it unless necessary. Febuxostat tablets can be secreted into breast milk in animal experiments, but there are no studies in humans and its use is not recommended. To learn more about febuxostat-related drug information, patients can consult a medical companion.
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)